Literature DB >> 30308252

Bioengineering a novel 3D in vitro model of gastric mucosa for stomach permeability studies.

Bianca N Lourenço1, Tiago Dos Santos2, Carla Oliveira3, Cristina C Barrias4, Pedro L Granja5.   

Abstract

The field of stomach-directed therapeutics and diagnosis is still hampered by the lack of reliable in vitro models that closely mimic the gastric mucosa where gastric cancer cells are generally confined. Here we propose a rapid, complex, and innovative 3D in vitro model of the gastric mucosa, by extending a conventional gastric monolayer model to an inner stratum of the mucosa - the lamina propria. The developed model comprises normal stomach fibroblasts embedded in a 3D RGD-modified alginate hydrogel prepared on the basolateral side of a Transwell® insert, mimicking the extracellular matrix and cellular component of the lamina propria, onto which a moderately differentiated adenocarcinoma stomach cell line (MKN74) was seeded, reproducing the physiological conditions of the gastric barrier. The integrity and functionality of the in vitro model was evaluated through permeability studies of FITC-dextran and 200 nm fluorescent polystyrene nanoparticles at gastric conditions. Nanoparticle transport was pH-dependent and strongly impacted by the biomimetic lamina propria, highlighting that a gastric extracellular matrix (ECM)-like microenvironment should be integrated in an in vitro permeability model to be adopted as a reliable evaluation tool of innovative therapeutics and diagnosis of gastric diseases. STATEMENT OF SIGNIFICANCE: Current in vitro models of the gastric mucosa are limited to simplistic 2D cell culture systems, which ignore the dimensionality of the stomach wall and make it difficult to reliably test new therapeutic approaches to gastric pathologies. By combining stomach fibroblasts embedded within a 3D RGD-modified alginate hydrogel and epithelial gastric cancer cells in a Transwell® system, we established a new biomimetic model of the stomach mucosa. Epithelial cells recreate the gastric epithelium, while the cell-laden 3D hydrogel recapitulates both the cellular composition and dimensionality of the extracellular matrix of gastric lamina propria. This cellularized 3D model stands as a promising evaluation platform to assist the development of new strategies for the treatment and diagnosis of gastric diseases.
Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alginate hydrogel; Extracellular matrix (ECM); Gastric mucosa; In vitro model; Polystyrene nanoparticles; Stomach fibroblasts

Mesh:

Substances:

Year:  2018        PMID: 30308252     DOI: 10.1016/j.actbio.2018.10.007

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  4 in total

1.  Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells.

Authors:  Bianca N Lourenço; Rúben F Pereira; Cristina C Barrias; Claudia Fischbach; Carla Oliveira; Pedro L Granja
Journal:  Nanomaterials (Basel)       Date:  2021-01-23       Impact factor: 5.076

2.  A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators.

Authors:  Daniel A Ferreira; Mario Rothbauer; João P Conde; Peter Ertl; Carla Oliveira; Pedro L Granja
Journal:  Adv Sci (Weinh)       Date:  2021-02-08       Impact factor: 16.806

Review 3.  Towards bioinspired in vitro models of intestinal mucus.

Authors:  Lorenzo Sardelli; Daniela Peneda Pacheco; Anna Ziccarelli; Marta Tunesi; Omar Caspani; Andrea Fusari; Francesco Briatico Vangosa; Carmen Giordano; Paola Petrini
Journal:  RSC Adv       Date:  2019-05-21       Impact factor: 4.036

4.  Succinylation Inhibits the Enzymatic Hydrolysis of the Extracellular Matrix Protein Fibrillin 1 and Promotes Gastric Cancer Progression.

Authors:  Xingyun Wang; Xiao Shi; Hongcheng Lu; Chen Zhang; Xiang Li; Tiancheng Zhang; Jiajia Shen; Jianfei Wen
Journal:  Adv Sci (Weinh)       Date:  2022-07-28       Impact factor: 17.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.